One new and three known triterpenoid saponins were isolated and identified from Camellia oleifera seeds through IR, NMR, HR-ESI-MS and GC-MS spectroscopic methods, namely oleiferasaponin A 3 , oleiferasaponin A 1 , camelliasaponin B 1 , and camelliasaponin B 2 . The structure of oleiferasaponin A 3 was elucidated as 16α-hydroxy-
Introduction
Triterpenoid saponins are vital plant secondary metabolites that have been applied to cosmetics [1, 2] , agriculture [3] , and medicine [4, 5] for their diverse biological and pharmacological activities. Camellia oleifera was named for its seeds with plentiful edible oil. Tea seed pomace-the byproduct of oil manufacture-contains about 8% saponins, which have historically been wasted without full use [6] . In recent years, some research works concerning the extraction, structures, and activity identification of saponins obtained from Camellia oleifera seed have been published. There are 11 novel triterpenoid saponin compounds obtained from Camellia oleifera seed [6] [7] [8] [9] [10] [11] [12] [13] . Meanwhile, their cell protective activity [14] , antioxidant activity [10, 15] , anti-fungal activity [16, 17] , cytotoxic activity [11] [12] [13] 18] have been reported, indicating that the different activities depend on the different compound structures. Approximately 30 types of saponin were indicated by liquid chromatography-mass spectrometry (LC-MS) analysis in the seed pomace of Camellia oleifera [17] . Therefore, it is significant to continue extracting, identifying, and exploring the biological and pharmacological activities of saponins in Camellia oleifera seed pomace.
One new triterpenoid saponin (oleiferasaponin A 3 ) and three known saponins (oleiferasaponin A 1 , camelliasaponin B 1 , and camelliasaponin B 2 ) were isolated from the tea seed pomace of Camellia oleifera in our study. We observed that camelliasaponin B 1 and camelliasaponin B 2 significantly inhibited the proliferation of human lung cancer cells (A549), human liver cancer cells (HepG2), cervical cancer cells (Hela), especially A549 cell lines. In addition, a glucose-stimulated insulin secretion (GSIS) experiment 
Anti-Proliferative Activity
Oleiferasaponin A1, oleiferasaponin A3, camelliasaponin B1 and camelliasaponin B2 obtained from Camellia oleifera seed pomace were tested against three human tumour cell lines (A549, Hela, HepG2) using cell proliferation bioassay (SRB). Camelliasaponin B1 and camelliasaponin B2 at the Hz, H-1 ), and δc 103.4 (C-1' of glucuronopyranosyl, GlcA), 106.2 (C-1"" of xylopyranosyl, Xyl), 101.2 (C-1 of galactopyranosyl, Gal), 100.2 (C-1 of Gal), respectively, which indicated the presence of four sugar residues. In addition, a cinnamoyl group (δ H 6.49, 7.72 (1H, d, J = 16.0 Hz, Cin-H-2, Cin-H-3), 7.42, 7.42, 7.42, 7.60, 7.60 (1H, m, Cin-H-6, 7, 8, 9, 5), 117.4 (Cin-C-2), 127.8 (Cin-C-5, 9), 128.6 (Cin-C-6, 8), 130.1 (Cin-C-7), 134.4 (Cin-C-4), 145.3 (Cin-C-3), and δ C 167.6 (Cin-C-1)), and an angeloyl group (δ H 6.02 (1H, q, 22-O-Ang-3), 1.85 (3H, d, J = 7.2 Hz, 22-O-Ang-4), 1.82 (3H, s, 22-O-Ang-5)), which are also present in isotheasaponins B 3 isolated from the leaves of the tea plant Camellia sinensis var. sinensis [19] (1H, s, H-23) ). The positions of the Ang, Cin group and sugar components in oleiferasaponin A 3 were clarified by an HMBC experiment (Figure 2 ), which showed a correlation between δ H 6.04 (10.2) (H, d, H-21) and δ C 168.1 of Ang-C-1, δ H 5.62 (10.2) (H, d, H-22) and δ C 167.6 of Cin-C-1, as well as GlcA-H-1 and δ C 84.7 (C-3 of the aglycone), Gal-H-1 and δ C 77 (GlcA-C-2 ), Gal-H-1 and δ C 81.6 (GlcA-C-3 ), Xyl-H-1 and δ C 82.4 (Gal-C-2'). 
Oleiferasaponin A1, oleiferasaponin A3, camelliasaponin B1 and camelliasaponin B2 obtained from Camellia oleifera seed pomace were tested against three human tumour cell lines (A549, Hela, HepG2) using cell proliferation bioassay (SRB). Camelliasaponin B1 and camelliasaponin B2 at the concentration of 20 μM exhibited effective anti-proliferative activity on the human tumour cell lines tested ( Figure 3 )-the inhibition ratios were more than 50%. Camelliasaponin B1 and camelliasaponin B2 at the concentration of 10 μM significantly inhibited the proliferation of human lung cancer cells (A549) (Figure 3 )-the inhibition ratios were 94.44% and 79.12%, respectively. Our results indicated that camelliasaponin B1 and camelliasaponin B2 possessed potent cytotoxic activity. There are some reports about the structure-activity relationships of triterpenoid saponins [21, 22] . The NOESY spectrum showed the cross peaks between H-22 at δ H 5.62 and H-30 at δ H 1.14, as well as those between H-16 at δ H 4.06 and H-28 at δ H 3.02, 3.33, suggesting that H-22 and H-16 are both β-oriented; that is, Cin group at C-22 and 16-OH group are both α-orientations. The H-3 at δ H 3.90 correlated with H-23 at δ H 9.50 and H-21 at δ H 6.04 correlated with H-29 at δ H 0.93, indicating that the glycosidic chain group at C-3 and Ang group at C-21 are β-configured. The absolute configuration of sugars of oleiferasaponin A 3 was confirmed by acid hydrolysis and GC-MS analysis, which revealed one unit of D-glucuronic acid (GlcA), two units of D-galactose (Gal) and one unit of D-xylose (Xyl) [13, 20] . Synthesizing the above analysis of all the proton and carbon signals, we established the structure of oleiferasaponin A 3 as 16α-hydroxy-
The other three known compounds were oleiferasaponin A 1 (22- 
Oleiferasaponin A 1 , oleiferasaponin A 3 , camelliasaponin B 1 and camelliasaponin B 2 obtained from Camellia oleifera seed pomace were tested against three human tumour cell lines (A549, Hela, HepG2) using cell proliferation bioassay (SRB). Camelliasaponin B 1 and camelliasaponin B 2 at the concentration of 20 µM exhibited effective anti-proliferative activity on the human tumour cell lines tested (Figure 3 )-the inhibition ratios were more than 50%. Camelliasaponin B 1 and camelliasaponin B 2 at the concentration of 10 µM significantly inhibited the proliferation of human lung cancer cells (A549) (Figure 3 )-the inhibition ratios were 94.44% and 79.12%, respectively. Our results indicated that camelliasaponin B 1 and camelliasaponin B 2 possessed potent cytotoxic activity. There are some reports about the structure-activity relationships of triterpenoid saponins [21, 22] .
The 
Hypoglycemic Activity
Diabetes mellitus (DM) is the third most prevalent disease globally, and manifests as a disorder of blood glucose caused by metabolic disorder, which can induce cardiovascular system diseases and cancer, then threatening human health and life. Many studies regarding the cytotoxic activity of triterpenoid saponins have been reported [11] [12] [13] , while few have been conducted concerning hypoglycemic activity [23] . Oleiferasaponin A1 and oleiferasaponin A3 did not exhibit cytotoxic activity on three human tumour cell lines (A549, Hela, HepG2), so we carried out a hypoglycemic activity study for further exploration of structure-activity relationship. Oleiferasaponin A1 and oleiferasaponin A3 were tested for their protective effect on RIN-m5f (islet-β cells) injured by high glucose. The insulin content of RIN-m5f cells upon treatment under 16.7 mmol/L glucose are shown below (Figure 4 ). With higher oleiferasaponin A1 concentration, the insulin levels of RIN-m5f (islet-β cells) was enhanced, which indicates that oleiferasaponin A1 has potential hypoglycemic activity against the damage induced by high glucose, and oleiferasaponin A1 may be a therapeutic agent for hyperglycemia treatment. Regarding the oleiferasaponin A3 group, no improvement effect on insulin levels was found in RIN-m5f (islet-β cells) injured by high glucose, even at a concentration of 100 μM. The difference of bioactivity between oleiferasaponin A1 and oleiferasaponin A3 is due to the different structure, including aglycone and sugar moieties (Figure 1) . Compared with oleiferasaponin A3, we infer that the trans-2-hexenoyl group of oleiferasaponin A1 at C-22 may influence the activities, cooperating with sugar moieties. The structures of camelliasaponin B 1 and camelliasaponin B 2 are similar, except for the orientation of C-22 angeloyl. Compared to previously reported results [11] [12] [13] , it seems that the main groups contributing cytotoxicity are the C-22 Ang group and the C-28 free hydroxy group. As a result, the cytotoxic activity is a combined effect of sugar moieties and aglycone, rather than an isolated structural effect. Oleiferasaponin A 1 and oleiferasaponin A 3 did not show cytotoxic activity.
Diabetes mellitus (DM) is the third most prevalent disease globally, and manifests as a disorder of blood glucose caused by metabolic disorder, which can induce cardiovascular system diseases and cancer, then threatening human health and life. Many studies regarding the cytotoxic activity of triterpenoid saponins have been reported [11] [12] [13] , while few have been conducted concerning hypoglycemic activity [23] . Oleiferasaponin A 1 and oleiferasaponin A 3 did not exhibit cytotoxic activity on three human tumour cell lines (A549, Hela, HepG2), so we carried out a hypoglycemic activity study for further exploration of structure-activity relationship. Oleiferasaponin A 1 and oleiferasaponin A 3 were tested for their protective effect on RIN-m5f (islet-β cells) injured by high glucose. The insulin content of RIN-m5f cells upon treatment under 16.7 mmol/L glucose are shown below (Figure 4) . With higher oleiferasaponin A 1 concentration, the insulin levels of RIN-m5f (islet-β cells) was enhanced, which indicates that oleiferasaponin A 1 has potential hypoglycemic activity against the damage induced by high glucose, and oleiferasaponin A 1 may be a therapeutic agent for hyperglycemia treatment. Regarding the oleiferasaponin A 3 group, no improvement effect on insulin levels was found in RIN-m5f (islet-β cells) injured by high glucose, even at a concentration of 100 µM. The difference of bioactivity between oleiferasaponin A 1 and oleiferasaponin A 3 is due to the different structure, including aglycone and sugar moieties (Figure 1) . Compared with oleiferasaponin A 3 , we infer that the trans-2-hexenoyl group of oleiferasaponin A 1 at C-22 may influence the activities, cooperating with sugar moieties. 
Materials and Methods

General
HPLC was run on Agilent 1260 HPLC (Agilent, Palo Alto, CA, USA). IR (infrared) spectra was recorded on Nicolet iN10 (Thermo Scientific Instrument Co., Boston, MA, USA) with KBr pellets. NMR spectra was measured on an AVANCE III (600 MHz) spectrometer (Bruker, Fallanden, Switzerland) using methanol-d4 (Sigma-Aldrich St. Louis, MO, USA) as solvent. HR-ESI-MS were determined on an electrostatic field orbital trap mass spectrometer (Thermo Scientific, Bremen, Germany) using an ESI source.
Plant Material
Tea seed pomace (Camellia oleifera) was collected from a factory in Shucheng, Anhui province, China. The plant material was identified by one of the authors (Associate Prof. X.F. Zhang), and was deposited in State Key Laboratory of Tea Plant Biology and Utilization, Anhui Agricultural University.
Extraction and Isolation
The samples were extracted and isolated according to Zhang et al. [10] . The tea seed powder 10 kg) was extracted three times with methanol at 60 °C under reflux each for 3 h. Concentrated solution (1.3 kg) was obtained after solvent evaporation under reduced pressure. The methanol extract (1.0 kg) was suspended in water and purified by nanofiltration membrane (SJM, Hefei, Anhui, China). Then, the purified solution (0.6 kg) was successively subjected to AB-8 macroporous resin column (Bonc, Cangzhou, Herbei, China), ordinary-phase silica gel column to yield a high-purity fraction (0.96 g), which was purified by HPLC (MeOH:H2O, 30:70) to furnish two saponin mixtures (Fr. 1, 0.13 g; Fr. 2, 0.17 g). The first faction was further purified by HPLC (acetonitrile-0.2% AcOH:H2O, 41:59, v/v) to afford oleiferasaponin A1 (8.7 mg) and oleiferasaponin A3 (3.9 mg). The second faction was further purified by HPLC (acetonitrile-0.2% AcOH:H2O, 37:63, v/v) to camelliasaponin B1 (11.6 mg) and camelliasaponin B2 (9.9 mg). 
Materials and Methods
General
HPLC was run on Agilent 1260 HPLC (Agilent, Palo Alto, CA, USA). IR (infrared) spectra was recorded on Nicolet iN10 (Thermo Scientific Instrument Co., Boston, MA, USA) with KBr pellets. NMR spectra was measured on an AVANCE III (600 MHz) spectrometer (Bruker, Fallanden, Switzerland) using methanol-d 4 (Sigma-Aldrich St. Louis, MO, USA) as solvent. HR-ESI-MS were determined on an electrostatic field orbital trap mass spectrometer (Thermo Scientific, Bremen, Germany) using an ESI source.
Plant Material
Extraction and Isolation
The samples were extracted and isolated according to Zhang et al. [10] . The tea seed powder 10 kg) was extracted three times with methanol at 60 • C under reflux each for 3 h. Concentrated solution (1.3 kg) was obtained after solvent evaporation under reduced pressure. The methanol extract (1.0 kg) was suspended in water and purified by nanofiltration membrane (SJM, Hefei, Anhui, China). Then, the purified solution (0.6 kg) was successively subjected to AB-8 macroporous resin column (Bonc, Cangzhou, Herbei, China), ordinary-phase silica gel column to yield a high-purity fraction (0.96 g), which was purified by HPLC (MeOH:H 2 O, 30:70) to furnish two saponin mixtures (Fr. 1, 0.13 g; Fr. 2, 0.17 g). The first faction was further purified by HPLC (acetonitrile-0.2% AcOH:H 2 O, 41:59, v/v) to afford oleiferasaponin A 1 (8.7 mg) and oleiferasaponin A 3 (3.9 mg). The second faction was further purified by HPLC (acetonitrile-0.2% AcOH:H 2 O, 37:63, v/v) to camelliasaponin B 1 (11.6 mg) and camelliasaponin B 2 (9.9 mg). Each group was set three parallels and incubated for 48 h. Next, the medium was removed, cleaning twice with polybutylene succinate (PBS). The cells were incubated in medium with 5.5 mmol L −1 glucose for 1 h. Then, the medium was replaced by medium with 33.3 mmol L −1 glucose and incubated for 2 h. The supernatant was collected for insulin content detection using ELISA kit (CEA448Ra, Cloud-Clone Corp, Houston, TX, USA).
Acid Hydrolysis and GC-MS Analysis
Conclusions
Four triterpenoid saponins were isolated from Camellia oleifera Abel. seed pomace: oleiferasaponin A 3 , oleiferasaponin A 1 , camelliasaponin B 1 , and camelliasaponin B 2 . The structure of oleiferasaponin A 3 was identified. Camelliasaponin B 1 and camelliasaponin B 2 exhibited potent cytotoxic activity on three human tumour cell lines (A549, HepG2, Hela). Oleiferasaponin A 1 possessed potential hypoglycemic activity protecting pancreatic β-cell lines from high-glucose damage.
Supplementary Materials: HR-ESR-MS and NMR spectra data of oleiferasaponin A 3 can be accessed online.
